BAMCO Inc
QGENF

BAMCO Inc’s QIAGEN NV QGENF Stock Holding History

BAMCO Inc’s Portfolio QGENF Stock Details QGENF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-10,200
Closed -$236K – 383
2013
Q4 		$236K Sell
10,200
-9,800
-49% -$227K ﹤0.01% 327
2013
Q3 		$428K Hold
20,000
– – ﹤0.01% 290
2013
Q2 		$398K Buy
+20,000
New +$398K ﹤0.01% 279

Other funds holding QGENF

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $10.6B AUM 19.39% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Credit Agricole
Credit Agricole Montrouge Cedex, France $49.3B AUM 36.45% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
MNA
Manning & Napier Advisors Fairport, New York $7.8B AUM 25.03% 1-Year Est. Return
HJGA
Hardman Johnston Global Advisors Stamford, Connecticut $2.85B AUM 35.77% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
CRM
Cramer Rosenthal McGlynn Stamford, Connecticut $1.98B AUM 60.71% 1-Year Est. Return

BAMCO Inc's QGENF Position: Q1 2014 in Review

BAMCO Inc sold out of QIAGEN NV (QGENF) in Q1 2014, closing a stake of 10,200 shares — an estimated $236K sold.

BAMCO Inc first reported a position in QGENF in Q2 2013 and held it in 3 quarters. The position peaked at $428K in Q3 2013. 166 funds tracked by Wall St. Rank hold QGENF as of Q1 2014.

  • BAMCO Inc reported no remaining QIAGEN NV position as of Q1 2014 after selling out during the quarter.
  • BAMCO Inc sold 10,200 QIAGEN NV shares in Q1 2014, an estimated $236K.
  • BAMCO Inc first reported a position in QIAGEN NV in Q2 2013 and held it in 3 quarters.
  • BAMCO Inc's QIAGEN NV position peaked at $428K in Q3 2013.
  • 166 funds tracked by Wall St. Rank held QIAGEN NV as of Q1 2014.

Based on BAMCO Inc's 13F filing for Q1 2014, filed 15 May 2014.